Accessibility Menu
Onconetix Stock Quote

Onconetix (NASDAQ: BWV)

Some price data may be temporarily unavailable.

KEY DATA POINTS

Current Price
N/A
Daily Change
N/A
Day's Range
N/A
Previous Close
N/A
Open
N/A
Beta
N/A
Volume
N/A
Average Volume
N/A
Market Cap
N/A
Market Cap / Employee
N/A
52wk Range
N/A
Revenue
N/A
Gross Margin
N/A
Dividend Yield
N/A
EPS
N/A
CAPs Rating
N/A
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Onconetix Company Info

Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH.

News & Analysis

No results found

No news articles found for Onconetix.

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.